BioMap and JinXin Tech Forge Strategic Partnership to Build the World's Leading AI-Powered Assisted Reproductive Technology (ART) Intelligence Platform

Recently, BioMap, the global pioneer in foundational large models for life sciences, and Jinxin Technology, the leader in China's assisted reproductive services, officially announced a strategic partnership. Both parties will leverage their respective strengths and complementary resources to jointly build an assisted reproductive platform.AI Intelligent System——The World's Leading Intelligent Platform for Assisted Reproductive Technology, ThroughAI Deep technology empowers the reproductive process to improve efficiency standardization, industry decision-making datafication, cycle trend deduction optimization, and the upgrading of medical team training systems, while jointly exploring cutting-edge fields, ultimately achieving...IVF Optimization of Assisted Reproductive Processes and Enhancement of Service Experience.

Jinxin Technology, based on Jinxin Fertility Group's decades of specialized experience in the field of female health and fertility, continues to deepen its expertise in this area and has independently developed multiple innovations in female health and fertility.AI Digital products and integrated solutions for agents, which have been widely used in dozens of medical institutions at home and abroad. BioMap, based on its unique large foundational model technology in life sciences, has already made strides in drug research and development, biomanufacturing, basic scientific research, and healthcare.200 More than 10 tasks have achieved the current best level in the industry, and dozens of professional细分fields...700 BioMap provides large model-driven expertise to clients worldwide.AI Agent, integrating data, models, and experimental capabilities, delivers cutting-edge application outcomes for users in areas such as advanced drug discovery, improved bioresponse efficiency, biological data interpretation, and knowledge acquisition.

Currently, the penetration rate of assisted reproductive technology in China is generally low, with the core bottleneck being the uneven distribution of high-quality medical resources and the insufficient standardization of medical procedures. The combination of BioMap's life science large model and Jinxin Technology's industry experience is breaking this deadlock: through the full-process companionship of client-side agents, it can...IVF The time for organizing cycle information is significantly reduced, alleviating anxiety caused by omissions; the personalized assisted reproduction intelligence system on the team side can provide medical institutions with multi-dimensional statistical analysis and computational tools based on desensitized medical data.

The above-mentioned path to breakthrough includes the completion of the following specific tasks: building a structured integration of Jinxin data and literature.IVF Knowledge Base; Build team-end agents to improve customer service efficiency and standardization; Build client-end information service system agents to optimize medical experience and service satisfaction; Establish a multimodal data fusion mechanism to support continuous model optimization and multi-task capability expansion; Connect the periodic data chain to achieve structured沉淀; Build the Jinxin case library and teaching-research platform to support rapid growth of new teams and multi-agent deployment replication. Ultimately, both parties achieve resource sharing.+Technical complementarity, completing the construction combined with Jinxin's industry experience/Data and BioMap's "Assisted Reproductive Intelligence Cluster".

"Jinxin Assisted Reproduction Intelligent Agent Cluster" will respectively build an intelligent agent cluster developed for the client side (includingIVF Knowledge Assistant Agent, Treatment Cycle Guidance Agent, Follow-up and Rehabilitation Guidance Agent), covering the entire service process from pre-service to post-service; and the agent system constructed for professional teams (includingIVF Intelligent agents for inquiry and case management, personalized application solution generation, embryo parameter recording and laboratory collaboration, and research and teaching assistance, thereby accumulating knowledge and experience, iterating the knowledge graph, and improving medical efficiency; finally, a multi-module intelligent agent system for female reproduction is provided, achieving a usable and deployable product form.。

The significance of this cooperation between the two parties goes far beyond the technical叠加 in a single field; it is more about injecting "AI+New Momentum for "Biological Intelligence Evolution." In the future, both parties will jointly exploreAI Driven personalized application solutions, building dynamic treatment models, achieving from ovulation induction dose recording to embryo transferFull-process Data Support; Create an exclusive domain for women and children's healthAI Intelligent agent, providing full-cycle parenting knowledge services, developmental warning, and emotional interaction services; initiating a new paradigm in assisted reproductive research, breaking data silos, building cross-modal reproductive large models, exploring reproductive aging mechanisms, and offering potential research directions for ovarian function maintenance. WithAI The implementation of auxiliary reproductive intelligence clusters in multiple pilot hospitals of Jin Xin marks the beginning of a reproductive medicine revolution—from experience-driven to data intelligence.

About Jinxin Technology

As Jinxin Fertility Group (01951.HK) incubated technology enterprises, Jinxin Technology, based on the group's decades of specialized experience in the field of women's health and fertility, continues to deepen its expertise in this area and has independently developedEMRObstetrics and Assisted Reproduction Electronic Medical Record System,HSCRMMedical Customer Service Operation System and Women's Health and FertilityAIDigital products such as agents, these products and integrated solutions have been widely used in dozens of medical institutions at home and abroad.2025In the year, Jinxin Technology collaborated with multiple topAI+Medical enterprise cooperation has further strengthened the R&D capability.